Medical probe steriliser Nanosonics has hit the US double jackpot, with the FDA approving iterations of its original Trophon device.

Reports record revenue of $20.4 million for the second quarter of 2025, an increase of $2.5 million, or 14%, compared to the ...

Alex Able, 30, has been undergoing treatment for a very rare cancer, and finally had enough and asked to go home, but now ...

Artificial Intelligence (AI) is revolutionizing the public health landscape by enabling sophisticated data analytics, ...

Advances in artificial intelligence (AI) are revolutionizing the way we observe, quantify, and interpret the microscopic ...

A groundbreaking ceremony for the new Aspirus Health hospital along Chippewa Crossing Boulevard in Chippewa Falls is set for ...

Vlier LMS anti-vibration levelers provide an advanced solution. Engineered to control vibration and absorb shock, the LMS ...

Background Cancer survivors have an increased risk of heart failure, but this is balanced by the risk of death from other ...

More fireflies than usual are lighting up summer evenings in the U.S. Northeast. But scientists say the lightning bugs are ...

A Senate committee has advanced the nomination of President Donald Trump's pick to lead the Cybersecurity and Infrastructure ...

Castle Biosciences will hold a conference call on Monday, August 4, 2025, at 4:30 p.m. Eastern time to discuss its second quarter 2025 results and provide a corporate update.

This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...